Yes another new lawsuit check the news. Wow all this great news lowering forcasts and missing expectations. Debt is over $2.4 billion. Thats BILLIONS in debt, this is not including the costs to fix the FDA problems, recalls, or recent lawsuis and litigaion. $25 million attributable to our acquisition of Advanced Bionics. The remainder of the growth in our research and development spending reflects investments to enhance our clinical and regulatory infrastructure and provide additional funding for research and development on next-generation and novel technology offerings across multiple programs and divisions. our research and development expenses increased by $109 million, or 32 percent, , research and development expenses increased The increase related primarily to an increased investment of $55 million in our drug-eluting stent franchise. Advance bionics was a TOTAL WASTE OF MONEY, $25 MILLION DOWN THE TOILET. Thats just the start, all that money invested in stents and the FDA is about to remove them from the market.